Navigation Links
Adeona to Host Investor Day on Zinc Deficiency in Alzheimer's Disease
Date:1/18/2011

long the Briarwood Shopping Mall circle, only 2.5 miles from downtown Ann Arbor and the University of Michigan, and 25 miles from Detroit Metropolitan Airport. The hotel address is: 610 Hilton Blvd., Ann Arbor, MI. 48108.

About Adeona Pharmaceuticals, Inc.

Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company's strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is developing the following product candidates: a prescription medical food for Alzheimer's disease, and drugs for multiple sclerosis, fibromyalgia, rheumatoid arthritis and age-related macular degeneration. For more information, please visit Adeona's website at www.adeonapharma.com.

This release includes forward-looking statements on Adeona's current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the timing and results of our clinical study and our ability to successfully develop products with superior benefits. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, a failure of our clinical 
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Adeona to Present at OneMedForum San Francisco 2011 Conference
2. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
3. Adeona Announces Third Quarter 2010 Financial Results and Achievements
4. Adeona to Hold Annual Shareholder Meeting
5. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
6. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
7. Adeona Announces Second Quarter 2010 Profitability and Achievements
8. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
9. Adeona Announces HartLab Expansion Into Microbiology Testing Services
10. NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011
11. Watson to Host Investor Day on January 21 in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Valeant Pharmaceuticals International, ... the closing of its previously announced registered offering of ... (the "Offering"). Pursuant to the Offering, the Company ... per share, for aggregate gross proceeds of approximately $1.45 ... the U.S. Securities and Exchange Commission a final prospectus ...
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... , March 27, 2015   Hospira, ... leader in biosimilars and the world,s leading provider ... studies that support an evaluation of biosimilarity of ... Food and Drug Administration (FDA) conditionally approved name ... EPOGEN™ (epoetin alfa). These study data were presented ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... in Improving Symptoms and Urine Flow, With,Long Lasting ... 23, 2007 /PRNewswire-FirstCall/ -- Spectrum,Pharmaceuticals, Inc., today announced ... Company's drug candidate for the treatment,of benign prostatic ... held at the Anaheim Convention Center in,Anaheim, California ...
... WIRE)--May 23, 2007 - Northfield,Laboratories, Inc. (NASDAQ: ... III trauma trial with PolyHeme(R), its human,hemoglobin-based ... designed to seek an indication for use ... loss when transfusion is,required and red blood ...
Cached Medicine Technology:Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 2Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 3Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 4Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 5Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 6Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 7Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 8
(Date:3/29/2015)... 2015 The Contract Research Organizations ... research, manage data results and help develop and ... regulation standards. Contract research organizations (CROs) mainly serve ... sectors. Industry operators provide clients with a full ... research for Food and Drug Administration (FDA) approval. ...
(Date:3/29/2015)... Franklin, TN (PRWEB) March 29, 2015 ... for several PT Online Continuing Education Courses . ... - 10.0 hours of CME - TPTA, approval # ... Master the evaluation of the shoulder complex - 10.5 ... Course Approved #56400TX , Examination and Treatment of the ...
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... game with knights, nature, and peasants. , The ... to Eurogamer. The popularity of these games grew over ...
(Date:3/28/2015)... NY (PRWEB) March 28, 2015 Emergency ... offers urgent care in Manhattan, recently commemorated its three-year ... facility in Manhattan. In addition to 24-hour urgent care, ... facilities. , At this time, Emergency Medical Care’s ... abdominal pain, asthma, chest pain, eye injuries, ear infections, ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 One ... re-injury, according to research presented today at the American ... Day. The study examined the long term success of ... , “We examined survey data from 242 patients who ... author Justin P. Roe, MBBS, FRACS, from North Sydney ...
Breaking Medicine News(10 mins):Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
... Gardasil, study finds, , TUESDAY, Aug. 18 (HealthDay News) ... a cause of cervical cancer, appears safe, with relatively ... government study. , The study, which included data ... found that the rate of serious adverse events for ...
... ... specializing in healthy and natural dog treats announced today the official launch of its ... for a qualified veterinarian. All licensed U.S. veterinarians may list their practice in ... ...
... BURLINGTON, Mass., Aug. 18 Palomar Medical Technologies, ... developer of light-based systems for cosmetic treatments, announced today that ... confirmed the validity of all claims in the re-examination of ... Removal Using Optical Pulses." , , Rejecting ...
... , OAKLAND, Calif., Aug. 18 The ... Older Adults Maintain Independence: Advancing Technology Adoption," a briefing paper ... chronic health care and increasing the independence of older adults, ... "Spending on hospitalizations and chronic care management now exceeds ...
... , Price of Diabetes Prevention ... , , BETHESDA, Md., Aug. 18 ... with diabetes has been misconstrued during recent health care reform ... nation,s leading professional organization of doctors of podiatric medicine (DPMs), ...
... , , , ... (JCMC), the 488 bed, Magnet-designated flagship hospital of Mountain States Health Alliance (MSHA), ... Smart S q uare , the enterprise scheduling software ... live with Smart Square, JCMC has realized a savings of nearly $550,000 associated ...
Cached Medicine News:Health News:Cervical Cancer Vaccine Seems Safe 2Health News:Cervical Cancer Vaccine Seems Safe 3Health News:FidoDogTreats.com Launches Veterinarian Directory 2Health News:Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent 2Health News:Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent 3Health News:Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent 4Health News:Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent 5Health News:Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence 2Health News:Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence 3Health News:American Podiatric Medical Association Corrects President's Misstatement on Foot Amputation Costs 2Health News:Johnson City Medical Center Saves $550,000 with Smart Square(R) 2
... immunometric ('sandwich') EIA for the quantitative ... or plasma. LH in the sample ... antibodies directed at different epitopes. One ... and the other is labelled with ...
For the quantitative determination of luteinizing hormone (LH) concentration in human serum....
... a glycoprotein secreted by the anterior pituitary ... the intact LH molecule is a noncovalently-linked ... all have homologous alpha-subunits, however each hormone ... FSH production and secretion are stimulated by ...
Microwell-EIA for the detection of GAD Autoantibody....
Medicine Products: